MRI Interventions is a medical device company that develops and commercializes platforms for procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company has two product platforms: ClearPoint, in…
CytoDyn is a biotech company focused on developing new therapies for combating infection with immune deficiency viruses and other antibody applications. Its proprietary drug candidate PRO 140 is a humanized monoclonal antibody which has demonstrated…
Astex Pharmaceuticals is an innovative drug discovery, development and commercialization company focusing on therapeutics to fight against cancer and other life-threatening diseases. The company’s primary areas of focus are oncology and hematology. ASTX has established…
CollabRX is a data analytics company that uses cloud-based expert systems to inform healthcare decision-making. CLRX’s CollabRx Therapy Finders is a series of Web-based applications that provide information to physicians and patients for determining which…
Retrophin is a biotech company focused on discovering and developing treatments for rare and life-threatening diseases. RTRX is currently developing treatments for Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy and other…
SpectraScience is a medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The company’s WavSTAT…
Bioniche Life Sciences is a research-based biopharm company that discovers, develops, manufactures and markets proprietary products for human and animal health markets. The company operates three global business divisions: human health, animal health and food…
AmpliPhi Biosciences is a biotech company engaged in the development of anti-bacterial solutions to enhance human health through the application of its proprietary bacteriophage platform. Its lead product development programs target gram negative bacterial infections…
Richfield Oil & Gas, the Salt Lake City-headquartered oil and gas developer focused on production and further drilling to Arbukle targets on their Central Kansas Uplift assets, as well as their highly prospective leaseholds in…
Allied Healthcare Group is a diversified healthcare company focused on investing in next generation technologies, acquiring strategic assets to grow its product and service offerings. BOMDF operates in three businesses: Cordion, focused on vaccine technology…
NewLead Holdings is an international, vertically integrated shipping and commodity company that manages double-hull product tankers and dry bulk vessels. The company currently controls four vessels, two tankers, and two dry bulk ships. The company…
TNI BioTech is a biotech company engaged in combating fatal diseases through activating and mobilizing the body’s immune system using the company’s patented immunotherapy. The company’s products and immunotherapy technologies are designed to harness the…
Medtronic Neuromodulation is the second-oldest and fourth-largest business unit of Medtronic, Inc., the world’s leader in medical technology. Neuromodulation was formed as the company transferred its expertise in heart electrical stimulation for the treatment of…
Aradigm is engaged in developing inhalation drug products designed to improve the quality of life of patients with severe pulmonary disease. The company’s lead development candidates are formulations of the potent antibiotic ciprofloxacin (Pulmaquin (ARD-3150)…
Circadian Technologies is engaged in angiogenesis-based treatments for cancer. Focusing on a class of drug targets called Vascular Endothelial Growth Factors (VEGFs), the company seeks to develop truly novel therapies to extend and improve the…
Bacterin International Holdings is a developer, manufacturer and marketer of biologics products to domestic and international markets. The company’s proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold…
InVivo Therapeutics is focused on developing and commercializing technologies for the treatment of spinal cord injuries (SCI). The company’s aim is to develop/commercialize biocompatible polymer scaffolding devices to treat acute spinal cord injuries; biocompatible hydrogel…
ImmunoCellular Therapeutics is a clinical-stage biotech company focused on the development of novel immune-based products for the treatment of cancer. The product candidate portfolio includes cellular immunotherapies targeting cancer and cancer stem cell antigens, peptide…
Tvax Biomedical is a clinical stage drug development company advancing its novel targeted cell-based immunotherapy for the treatment of cancer. The company’s lead candidates, focused on treating brain and kidney cancer, are supported by positive…
CollabRX is a leader in cloud-based expert systems for informing healthcare decision-making. Beginning with the area of greatest need, which is advanced cancer in patients who have effectively exhausted the standard of care, the company…
Atossa Genetics is a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States. Its diagnostic tests include the ForeCYTE Breast…
Response Biomedical is a developer, manufacturer and marketer of rapid onsite diagnostics tests for use with its RAMP platform for clinical and environmental applications. Representing a new paradigm in diagnostics, RAMP provides reliable laboratory-quality results…
Oxygen Biotherapeutics is a development stage biomedical company engaged in the development of oxygen-rich intravenous and topical products. Oxycyte, the company’s proprietary perfluorocarbon (PFC) therapeutic oxygen carrier, is currently in clinical and preclinical studies for…
Repros Therapeutics is a development stage biopharmaceutical company focused on the development of oral small molecule drugs for major unmet medical needs in male and female health. The company’s current product pipeline includes Androxal®, in…
Pressure BioSciences engages in the development and commercialization of pressure cycling technology (PCT), a patented, enabling technology platform with multiple applications in the life sciences sample preparation market. PBIO’s focus is on the development and…
Synthetic Biologics is a biotechnology company developing product candidates for serious infections and diseases. The company is developing a biologic for preventing C. diff infection as well as a series of monoclonal antibodies (mAbs) for…
NeoStem, an emerging leader in the fast growing cell therapy market, announced the publication of papers as 2012 Annual Meeting Abstracts in the journal Blood, Volume 120, Issue 21. These publications were presented as abstracts…
Amarantus Bioscience is a development-stage biotech company focused on the discovery and development of therapeutic proteins and biologics for the treatment of Parkinson’s disease, traumatic brain injury (TBI) and other human diseases. The company owns…
Amtech Systems announced that the company’s subsidiary, Tempress Systems BV was awarded with the WNF Cleantech Star 2012, an award sponsored by the World Wide Fund for Nature The Netherlands in Rotterdam. Tempress was awarded…
Yesterday, the Bank of Hamption Roads’ (“BHR”) holding company, Hampton Roads Bankshares, Inc. (Nasdaq: HMPR), announced that Jean H. Sewell has joined its Shore Bank entity as Senior Vice President – Director of Marketing. Ms.…
Aethlon Medical is a development stage medical device company focused on creating devices for the treatment of cancer, infectious diseases and other life-threatening conditions. The company’s Aethlon Hemopurifier is intended for the treatment of cancer,…
Medbox, through its subsidiary Prescription Vending Machines Inc., engages in developing a patented machine that dispenses medication to individuals based on biometric identification. The company’s flagship product is MedBox, an automated medicine dispensing machine that…
Amorcyte is a biopharm company engaged in the development of proprietary cellular therapies in cardiovascular disease, immunology and regenerative medicine primarily in the United States. Its lead product candidate, AMR-001, which is for the prevention…
Atossa Genetics, known as The Breast Health Company, is engaged in the prevention of breast cancer through commercializing patented, FDA-approved diagnostic medical devices and patented, laboratory-developed tests for detecting precursors to breast cancer up to…
Athersys is a clinical stage biopharm company growing a pipeline of highly differentiated therapeutics to treat significant and life-threatening diseases. The company’s current product development portfolio consists of MultiStem®, a proprietary stem cell product for…
OncoSec Medical is a biotech company focused on the development of treatments addressing advanced-stage skin cancer, specifically: melanoma, Merkel cell lymphoma and cutaneous T-cell lymphoma. ONCS’ proprietary technology, OncoSec Medical System™ (OMS), is based on…
Neuralstem, a development-stage company focused on the development and commercialization of treatments for central nervous system disease, has developed and maintains a portfolio of patents and patent applications that form base for its research and…
Targeted Medical Pharma is a specialty pharmaceutical company engaged in developing and distributing prescription medical foods to physicians and pharmacies in the U.S. and the Middle East. The company manufactures 10 proprietary prescription-only medical foods…
ProMetic Life Sciences operates through a group of subsidiaries to specialize in the design of small molecules that mimic unique and specific interactions between proteins. The company’s technologies are applicable to large-scale drug purification, drug…
IntelGenx Technology is a drug delivery company engaged in developing oral controlled-release products and novel rapidly disintegrating delivery systems. Using its unique multiple layer delivery system, the company provides zero-order release of active drugs in…